Studies on the restriction of Murine Leukemia viruses by mouse APOBEC3

PLoS ONE

Volumn 7, Issue 5, 2012, Pages

  Sanchez Martinez, Silvia ^a   Aloia, Amanda L ^a,e   Harvin, Demetria ^a   Mirro, Jane ^a   Gorelick, Robert J ^b   Jern, Patric ^c   Coffin, John M ^d   Rein, Alan ^a  

^a FREDERICK NATIONAL LABORATORY FOR CANCER RESEARCH   (United States)

^b SAIC FREDERICK INC   (United States)

^c UPPSALA UNIVERSITY   (Sweden)

^d TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3; GAG PROTEIN; HYDROLASE; UNCLASSIFIED DRUG; VIRUS DNA; APOBEC3 PROTEIN, MOUSE; CYTIDINE DEAMINASE;

ARTICLE; CHIMERA; CONTROLLED STUDY; DEAMINATION; DNA SYNTHESIS; GROUP SPECIFIC ANTIGEN GENE; HUMAN IMMUNODEFICIENCY VIRUS 1; MOUSE; MURINE LEUKEMIA VIRUS; MUTATION; NONHUMAN; REVERSE TRANSCRIPTION; SEQUENCE ANALYSIS; VIRUS GENE; VIRUS GENOME; VIRUS INACTIVATION; VIRUS INFECTIVITY; ANIMAL; BIOSYNTHESIS; GENETIC TRANSFECTION; GENETICS; HUMAN; HYBRIDIZATION; METABOLISM; MOLONEY LEUKEMIA ONCOVIRUS; NUCLEOTIDE SEQUENCE; PATHOGENICITY; PHYSIOLOGY; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS 1; MOLONEY MURINE LEUKEMIA VIRUS; MURINE LEUKEMIA VIRUS;

ANIMALS; BASE SEQUENCE; CYTIDINE DEAMINASE; DNA, VIRAL; GENE PRODUCTS, GAG; HUMANS; HYBRIDIZATION, GENETIC; LEUKEMIA VIRUS, MURINE; MICE; MOLONEY MURINE LEUKEMIA VIRUS; TRANSFECTION; VIRUS REPLICATION;

EID: 84861561852     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0038190     Document Type: Article

References (34)

1. Harris RS, Liddament MT, (2004) Retroviral restriction by APOBEC proteins. Nat Rev Immunol 4: 868-877.
2. Sheehy AM, Gaddis NC, Choi JD, Malim MH, (2002) Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature 418: 646-650.
3. Holmes RK, Malim MH, Bishop KN, (2007) APOBEC-mediated viral restriction: not simply editing? Trends Biochem Sci 32: 118-128.
4. Iwatani Y, Chan DS, Wang F, Maynard KS, Sugiura W, et al. (2007) Deaminase-independent inhibition of HIV-1 reverse transcription by APOBEC3G. Nucleic Acids Res 35: 7096-7108.
5. Mbisa JL, Barr R, Thomas JA, Vandegraaff N, Dorweiler IJ, et al. (2007) Human Immunodeficiency Virus Type 1 cDNAs Produced in the Presence of APOBEC3G Exhibit Defects in Plus-Strand DNA Transfer and Integration. J Virol 81: 7099-7110.
6. Hakata Y, Landau NR, (2006) Reversed functional organization of mouse and human APOBEC3 cytidine deaminase domains. J Biol Chem 281: 36624-36631.
7. LaRue RS, Andresdottir V, Blanchard Y, Conticello SG, Derse D, et al. (2009) Guidelines for naming nonprimate APOBEC3 genes and proteins. J Virol 83: 494-497.
8. Low A, Okeoma CM, Lovsin N, de las Heras M, Taylor TH, et al. (2009) Enhanced replication and pathogenesis of Moloney murine leukemia virus in mice defective in the murine APOBEC3 gene. Virology 385: 455-463.
9. Santiago ML, Montano M, Benitez R, Messer RJ, Yonemoto W, et al. (2008) Apobec3 encodes Rfv3, a gene influencing neutralizing antibody control of retrovirus infection. Science 321: 1343-1346.
10. Smith DS, Guo K, Barrett BS, Heilman KJ, Evans LH, et al. (2011) Noninfectious retrovirus particles drive the apobec3/rfv3 dependent neutralizing antibody response. PLoS Pathog 7: e1002284.
11. Takeda E, Tsuji-Kawahara S, Sakamoto M, Langlois M-A, Neuberger MS, et al. (2008) Mouse APOBEC3 Restricts Friend Leukemia Virus Infection and Pathogenesis In Vivo. J Virol 82: 10998-11008.
12. Okeoma CM, Huegel AL, Lingappa J, Feldman MD, Ross SR, (2010) APOBEC3 proteins expressed in mammary epithelial cells are packaged into retroviruses and can restrict transmission of milk-borne virions. Cell Host Microbe 8: 534-543.
13. Okeoma CM, Lovsin N, Peterlin BM, Ross SR, (2007) APOBEC3 inhibits mouse mammary tumour virus replication in vivo. Nature 445: 927-930.
14. Okeoma CM, Petersen J, Ross SR, (2009) Expression of murine APOBEC3 alleles in different mouse strains and their effect on mouse mammary tumor virus infection. J Virol 83: 3029-3038.
15. Langlois MA, Kemmerich K, Rada C, Neuberger MS, (2009) The Akv Murine Leukemia Virus Is Restricted And Hypermutated By Mouse Apobec3. J Virol 83: 11550-11559.
16. Paprotka T, Venkatachari NJ, Chaipan C, Burdick R, Delviks-Frankenberry KA, et al. (2010) Inhibition of xenotropic murine leukemia virus-related virus by APOBEC3 proteins and antiviral drugs. J Virol 84: 5719-5729.
17. Stieler K, Fischer N, (2010) Apobec 3G Efficiently Reduces Infectivity of the Human Exogenous Gammaretrovirus XMRV. PLoS One 5: e11738.
18. Jern P, Stoye JP, Coffin JM, (2007) Role of APOBEC3 in genetic diversity among endogenous murine leukemia viruses. PLoS Genet 3: 2014-2022.
19. Browne EP, Littman DR, (2008) Species-specific restriction of apobec3-mediated hypermutation. J Virol 82: 1305-1313.
20. Rulli SJ Jr, Mirro J, Hill SA, Lloyd P, Gorelick RJ, et al. (2008) Interactions of Murine APOBEC3 and Human APOBEC3G with Murine Leukemia Viruses. J Virol 82: 6566-6575.
21. Edwards SA, Fan H, (1979) gag-Related polyproteins of Moloney murine leukemia virus: evidence for independent synthesis of glycosylated and unglycosylated forms. J Virol 30: 551-563.
22. Prats AC, De Billy G, Wang P, Darlix JL, (1989) CUG initiation codon used for the synthesis of a cell surface antigen coded by the murine leukemia virus. J Mol Biol 205: 363-372.
23. Kolokithas A, Rosenke K, Malik F, Hendrick D, Swanson L, et al. (2010) The glycosylated Gag protein of a murine leukemia virus inhibits the antiretroviral function of APOBEC3. J Virol 84: 10933-10936.
24. Elion EA, Marina P, Yu L, (2007) Constructing recombinant DNA molecules by PCR. Curr Protoc Mol Biol Chapter 3: Unit 3 17.
25. Derse D, Hill SA, Lloyd PA, Chung H, Morse BA, (2001) Examining human T-lymphotropic virus type 1 infection and replication by cell-free infection with recombinant virus vectors. J Virol 75: 8461-8468.
26. Miller AD, Miller DG, Garcia JV, Lynch CM, (1993) Use of retroviral vectors for gene transfer and expression. Methods Enzymol 217: 581-599.
27. Mariani R, Chen D, Schrofelbauer B, Navarro F, Konig R, et al. (2003) Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif. Cell 114: 21-31.
28. Albritton LM, Tseng L, Scadden D, Cunningham JM, (1989) A putative murine ecotropic retrovirus receptor gene encodes a multiple membrane-spanning protein and confers susceptibility to virus infection. Cell 57: 659-666.
29. Gorelick RJ, Chabot DJ, Ott DE, Gagliardi TD, Rein A, et al. (1996) Genetic analysis of the zinc finger in the Moloney murine leukemia virus nucleocapsid domain: replacement of zinc-coordinating residues with other zinc-coordinating residues yields noninfectious particles containing genomic RNA. J Virol 70: 2593-2597.
30. Gorelick RJ, Nigida SM Jr, Bess JW Jr, Arthur LO, Henderson LE, et al. (1990) Noninfectious human immunodeficiency virus type 1 mutants deficient in genomic RNA. J Virol 64: 3207-3211.
31. Fu W, Hu WS, (2003) Functional replacement of nucleocapsid flanking regions by heterologous counterparts with divergent primary sequences: effects of chimeric nucleocapsid on the retroviral replication cycle. J Virol 77: 754-761.
32. Gherghe C, Lombo T, Leonard CW, Datta SA, Bess JW Jr, et al. (2010) Definition of a high-affinity Gag recognition structure mediating packaging of a retroviral RNA genome. Proc Natl Acad Sci U S A 107: 19248-19253.
33. Rulli SJ Jr, Muriaux D, Nagashima K, Mirro J, Oshima M, et al. (2006) Mutant murine leukemia virus Gag proteins lacking proline at the N-terminus of the capsid domain block infectivity in virions containing wild-type Gag. Virology 347: 364-371.
34. Tamura K, Dudley J, Nei M, Kumar S, (2007) MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol 24: 1596-1599.